295 related articles for article (PubMed ID: 24078865)
1. Lentiviral vectors for cancer immunotherapy and clinical applications.
Liechtenstein T; Perez-Janices N; Escors D
Cancers (Basel); 2013 Sep; 5(3):815-37. PubMed ID: 24078865
[TBL] [Abstract][Full Text] [Related]
2. [Gene therapy using retrovirus vectors: vector development and biosafety at clinical trials].
Doi K; Takeuchi Y
Uirusu; 2015; 65(1):27-36. PubMed ID: 26923955
[TBL] [Abstract][Full Text] [Related]
3. Lentiviral vectors in cancer immunotherapy.
Oldham RA; Berinstein EM; Medin JA
Immunotherapy; 2015; 7(3):271-84. PubMed ID: 25804479
[TBL] [Abstract][Full Text] [Related]
4. From pathogen to medicine: HIV-1-derived lentiviral vectors as vehicles for dendritic cell based cancer immunotherapy.
Dullaers M; Thielemans K
J Gene Med; 2006 Jan; 8(1):3-17. PubMed ID: 16288497
[TBL] [Abstract][Full Text] [Related]
5. Efficiency of onco-retroviral and lentiviral gene transfer into primary mouse and human B-lymphocytes is pseudotype dependent.
Janssens W; Chuah MK; Naldini L; Follenzi A; Collen D; Saint-Remy JM; VandenDriessche T
Hum Gene Ther; 2003 Feb; 14(3):263-76. PubMed ID: 12639306
[TBL] [Abstract][Full Text] [Related]
6. Monitoring for potential adverse effects of prenatal gene therapy: genotoxicity analysis in vitro and on small animal models ex vivo and in vivo.
Themis M
Methods Mol Biol; 2012; 891():341-70. PubMed ID: 22648780
[TBL] [Abstract][Full Text] [Related]
7. Lentiviral vectors for cancer immunotherapy: transforming infectious particles into therapeutics.
Breckpot K; Aerts JL; Thielemans K
Gene Ther; 2007 Jun; 14(11):847-62. PubMed ID: 17361214
[TBL] [Abstract][Full Text] [Related]
8. Immune modulation by genetic modification of dendritic cells with lentiviral vectors.
Liechtenstein T; Perez-Janices N; Bricogne C; Lanna A; Dufait I; Goyvaerts C; Laranga R; Padella A; Arce F; Baratchian M; Ramirez N; Lopez N; Kochan G; Blanco-Luquin I; Guerrero-Setas D; Breckpot K; Escors D
Virus Res; 2013 Sep; 176(1-2):1-15. PubMed ID: 23726846
[TBL] [Abstract][Full Text] [Related]
9. Breast cancer vaccines delivered by dendritic cell-targeted lentivectors induce potent antitumor immune responses and protect mice from mammary tumor growth.
Bryson PD; Han X; Truong N; Wang P
Vaccine; 2017 Oct; 35(43):5842-5849. PubMed ID: 28916248
[TBL] [Abstract][Full Text] [Related]
10. Efficient gene transfer to human peripheral blood monocyte-derived dendritic cells using human immunodeficiency virus type 1-based lentiviral vectors.
Chinnasamy N; Chinnasamy D; Toso JF; Lapointe R; Candotti F; Morgan RA; Hwu P
Hum Gene Ther; 2000 Sep; 11(13):1901-9. PubMed ID: 10986562
[TBL] [Abstract][Full Text] [Related]
11. Lentiviral vectors for anti-tumor immunotherapy.
Breckpot K; Emeagi PU; Thielemans K
Curr Gene Ther; 2008 Dec; 8(6):438-48. PubMed ID: 19075627
[TBL] [Abstract][Full Text] [Related]
12. Biosafety challenges for use of lentiviral vectors in gene therapy.
Rothe M; Modlich U; Schambach A
Curr Gene Ther; 2013 Dec; 13(6):453-68. PubMed ID: 24195603
[TBL] [Abstract][Full Text] [Related]
13. Onco-retroviral and lentiviral vector-based gene therapy for hemophilia: preclinical studies.
Van Damme A; Chuah MK; Collen D; VandenDriessche T
Semin Thromb Hemost; 2004 Apr; 30(2):185-95. PubMed ID: 15118930
[TBL] [Abstract][Full Text] [Related]
14. Use of lentiviral vectors in vaccination.
Ku MW; Charneau P; Majlessi L
Expert Rev Vaccines; 2021 Dec; 20(12):1571-1586. PubMed ID: 34620025
[TBL] [Abstract][Full Text] [Related]
15. Targeting lentiviral vectors for cancer immunotherapy.
Arce F; Breckpot K; Collins M; Escors D
Curr Cancer Ther Rev; 2011 Nov; 7(4):248-260. PubMed ID: 22983382
[TBL] [Abstract][Full Text] [Related]
16. Optimization of lentiviral vectors generation for biomedical and clinical research purposes: contemporary trends in technology development and applications.
Kumar P; Woon-Khiong C
Curr Gene Ther; 2011 Apr; 11(2):144-53. PubMed ID: 21291355
[TBL] [Abstract][Full Text] [Related]
17. Emerging applications of lentiviral vectors in dendritic cell-based immunotherapy.
Wang H; Zhang L; Kung SK
Immunotherapy; 2010 Sep; 2(5):685-95. PubMed ID: 20874652
[TBL] [Abstract][Full Text] [Related]
18. Globin lentiviral vector insertions can perturb the expression of endogenous genes in beta-thalassemic hematopoietic cells.
Hargrove PW; Kepes S; Hanawa H; Obenauer JC; Pei D; Cheng C; Gray JT; Neale G; Persons DA
Mol Ther; 2008 Mar; 16(3):525-33. PubMed ID: 18195719
[TBL] [Abstract][Full Text] [Related]
19. Lentiviral vectors in gene therapy: their current status and future potential.
Escors D; Breckpot K
Arch Immunol Ther Exp (Warsz); 2010 Apr; 58(2):107-19. PubMed ID: 20143172
[TBL] [Abstract][Full Text] [Related]
20. [Progress in improvement of lentiviral vectors' transcriptional read-through].
He J; Zhang J
Sheng Wu Gong Cheng Xue Bao; 2011 Nov; 27(11):1541-8. PubMed ID: 22393708
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
